ID   COLO 720E
AC   CVCL_1995
SY   COLO 720 E; COLO-720E; COLO720E; Colo720E; Colorado 720E
DR   CLO; CLO_0002556
DR   CLDB; cl845
DR   cancercelllines; CVCL_1995
DR   Cosmic; 688126
DR   Cosmic; 1707568
DR   GEO; GSM711727
DR   IARC_TP53; 21240
DR   Wikidata; Q54814141
RX   PubMed=20164919;
RX   PubMed=22710073;
RX   PubMed=24023729;
CC   Problematic cell line: Partially contaminated. Some stocks are contaminated by COLO 704 (Cellosaurus=CVCL_AV69).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00438.
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Ala138Val (c.413C>T); ClinVar=VCV000184863; Zygosity=Heterozygous (PubMed=24023729).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; c.1118delA; Zygosity=Heterozygous (PubMed=24023729).
CC   Omics: SNP array analysis.
CC   Omics: Transcriptome analysis by microarray.
ST   Source(s): PubMed=22710073
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 8,11
ST   D16S539: 11
ST   D18S51: 12,16
ST   D19S433: 13,15.2
ST   D21S11: 28,32.2
ST   D2S1338: 18,24
ST   D3S1358: 15,17
ST   D5S818: 10,11
ST   D7S820: 10
ST   D8S1179: 10,13
ST   FGA: 21,25
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 14
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1863 ! COLO 720L
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 25
RX   PubMed=20164919; DOI=10.1038/nature08768;
RA   Bignell G.R., Greenman C.D., Davies H., Butler A.P., Edkins S.,
RA   Andrews J.M., Buck G., Chen L., Beare D., Latimer C., Widaa S.,
RA   Hinton J., Fahey C., Fu B.-Y., Swamy S., Dalgliesh G.L., Teh B.T.,
RA   Deloukas P., Yang F.-T., Campbell P.J., Futreal P.A., Stratton M.R.;
RT   "Signatures of mutation and selection in the cancer genome.";
RL   Nature 463:893-898(2010).
RX   PubMed=22710073; DOI=10.1016/j.ygyno.2012.06.017;
RA   Korch C.T., Spillman M.A., Jackson T.A., Jacobsen B.M., Murphy S.K.,
RA   Lessey B.A., Jordan V.C., Bradford A.P.;
RT   "DNA profiling analysis of endometrial and ovarian cell lines reveals
RT   misidentification, redundancy and contamination.";
RL   Gynecol. Oncol. 127:241-248(2012).
RX   PubMed=24023729; DOI=10.1371/journal.pone.0072162;
RA   Anglesio M.S., Wiegand K.C., Melnyk N., Chow C., Salamanca C.M.,
RA   Prentice L.M., Senz J., Yang W., Spillman M.A., Cochrane D.R.,
RA   Shumansky K., Shah S.P., Kalloger S.E., Huntsman D.G.;
RT   "Type-specific cell line models for type-specific ovarian cancer
RT   research.";
RL   PLoS ONE 8:E72162-E72162(2013).